These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9027185)

  • 21. Safety and immunogenicity of Salmonella typhi Ty21a liquid formulation vaccine in 4- to 6-year-old Thai children.
    Olanratmanee T; Levine M; Losonsky G; Thisyakorn V; Cryz SJ
    J Infect Dis; 1992 Aug; 166(2):451-2. PubMed ID: 1634818
    [No Abstract]   [Full Text] [Related]  

  • 22. Lack of immune response to the Vi component of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a in human studies.
    Tacket CO; Losonsky G; Taylor DN; Baron LS; Kopecko D; Cryz S; Levine MM
    J Infect Dis; 1991 Apr; 163(4):901-4. PubMed ID: 2010645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Typhoid fever--important issues still remain.
    Pang T; Levine MM; Ivanoff B; Wain J; Finlay BB
    Trends Microbiol; 1998 Apr; 6(4):131-3. PubMed ID: 9587187
    [No Abstract]   [Full Text] [Related]  

  • 24. A new look at typhoid vaccination. Information for the practicing physician.
    Woodruff BA; Pavia AT; Blake PA
    JAMA; 1991 Feb; 265(6):756-9. PubMed ID: 1990193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children.
    Mai NL; Phan VB; Vo AH; Tran CT; Lin FY; Bryla DA; Chu C; Schiloach J; Robbins JB; Schneerson R; Szu SC
    N Engl J Med; 2003 Oct; 349(14):1390-1. PubMed ID: 14523155
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of purified Vi polysaccharide typhoid vaccine.
    Park JH; Hong JJ; Choi ES; Lee JW; Park JH
    J Vet Sci; 2002 Jun; 3(2):67-70. PubMed ID: 12441674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever.
    Klugman KP; Gilbertson IT; Koornhof HJ; Robbins JB; Schneerson R; Schulz D; Cadoz M; Armand J
    Lancet; 1987 Nov; 2(8569):1165-9. PubMed ID: 2890805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative study of autoantibody formation following immunization with different types of typhoid vaccines].
    Negina IuP
    Zh Mikrobiol Epidemiol Immunobiol; 1980 May; (5):69-72. PubMed ID: 7415680
    [No Abstract]   [Full Text] [Related]  

  • 29. Nonspecific effects of oral vaccination with live-attenuated
    Pennington SH; Ferreira DM; Caamaño-Gutiérrez E; Reiné J; Hewitt C; Hyder-Wright AD; Gordon SB; Gordon MA
    Sci Adv; 2019 Feb; 5(2):eaau6849. PubMed ID: 30820452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host-Salmonella interaction: human trials.
    Levine MM; Tacket CO; Sztein MB
    Microbes Infect; 2001; 3(14-15):1271-9. PubMed ID: 11755415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single dose, combined vaccine against typhoid fever and hepatitis A: consistency, immunogenicity and reactogenicity.
    Beran J; Beutels M; Levie K; Van Damme P; Dieussaert I; Gillet M; Van Hoecke C; Tornieporth N
    J Travel Med; 2000; 7(5):246-52. PubMed ID: 11231208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?
    Kantele A; Pakkanen SH; Siitonen A; Karttunen R; Kantele JM
    Vaccine; 2012 Nov; 30(50):7238-45. PubMed ID: 23084770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of a new Salmonella Typhi Vi polysaccharide vaccine--vax-TyVi--in Cuban school children and teenagers.
    Azze RF; Rodríguez JC; Iniesta MG; Marchena XR; Alfonso VM; Padrón FT
    Vaccine; 2003 Jun; 21(21-22):2758-60. PubMed ID: 12798615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Re: typhoid fever vaccines: systematic review and meta-analysis of randomised clinical trials.
    Arya SC; Agarwal N
    Vaccine; 2008 Jan; 26(3):291. PubMed ID: 18082292
    [No Abstract]   [Full Text] [Related]  

  • 35. Typhoid vaccines.
    Aggarwal A; Dutta AK
    Indian J Pediatr; 2001 Aug; 68(8):733-6. PubMed ID: 11563251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph™) in Indian children: School based cluster randomized study.
    Mitra M; Shah N; Ghosh A; Chatterjee S; Kaur I; Bhattacharya N; Basu S
    Hum Vaccin Immunother; 2016 Apr; 12(4):939-45. PubMed ID: 26901576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salmonella-based vaccines.
    Hackett J
    Vaccine; 1990 Feb; 8(1):5-11. PubMed ID: 2180232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vivotif--a 'magic shield' for protection against typhoid fever and delivery of heterologous antigens.
    Gentschev I; Spreng S; Sieber H; Ures J; Mollet F; Collioud A; Pearman J; Griot-Wenk ME; Fensterle J; Rapp UR; Goebel W; Rothen SA; Dietrich G
    Chemotherapy; 2007; 53(3):177-80. PubMed ID: 17347563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The PhoP virulence regulon and live oral Salmonella vaccines.
    Miller SI; Loomis WP; Alpuche-Aranda C; Behlau I; Hohmann E
    Vaccine; 1993; 11(2):122-5. PubMed ID: 8438611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunochemical examination of typhoid and paratyphoid vaccines prepared from envelope and O antigens (author's transl)].
    Hatunceva NV; Mironova MV; Ryapolova RG
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):135-41. PubMed ID: 4216248
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.